CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI)

CUSIP: 163572209

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / COM NEW
Total 13F shares
7,300,513
Share change
+290,372
Total reported value
$23,729,372
Put/Call ratio
77%
Price per share
$3.25
Number of holders
73
Value change
-$2,295,643
Number of buys
54
Number of sells
25

Quarterly Holders Quick Answers

What is CUSIP 163572209?
CUSIP 163572209 identifies CEMI - CHEMBIO DIAGNOSTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) as of Q2 2020

As of 30 Jun 2020, CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) was held by 73 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,300,513 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, ROYCE & ASSOCIATES LP, KENNEDY CAPITAL MANAGEMENT, INC., SEGALL BRYANT & HAMILL, LLC, HEARTLAND ADVISORS INC, Nantahala Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, Penbrook Management LLC, and STATE STREET CORP. This page lists 73 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.